中文
・Target molecule: an IgM-form neutralizing antibody against SARS-CoV-2
・To be developed as a multi-dose nasal spray liquid formulation for mucosal protection
・Tight project timeline; full process from R&D to scale-up must be completed within an extremely short timeframe
・To be developed as a multi-dose nasal spray liquid formulation for mucosal protection
・Tight project timeline; full process from R&D to scale-up must be completed within an extremely short timeframe
